Welcome to our Corporate client solution
Your IP is registered with the company mentioned above and provides access to Life Science Sweden.
Click here to go to sign-up
Dentalbolaget Dentware siktar mot börsen. I samband med detta tar bolaget in nytt kapital.
En färsk studie visar att en substans som Astrazeneca ratade har effekt mot multipel skleros. I alla fall i djurstudier.